PS Ratio
18.53
-1.83-8.99%
Fri, 07 Feb 2025 21:00:01 GMT
Summary
- As of February 8, 2025, PRLD price to sales ratio is 18.53, with a fall of -1.83 (-8.99%) during the most recent trading day.
- PRLD PS ratio is now -52.35% below its all-time high of 38.89.
Performance
PRLD PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
PRLD PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -9.0% | -9.0% | -9.0% | - |
| 1 m1 month | -16.5% | -16.5% | -16.5% | - |
| 3 m3 months | -17.9% | -17.9% | -17.9% | - |
| 6 m6 months | - | -80.3% | -80.3% | - |
| ytdytd | -15.1% | -15.1% | -15.1% | - |
| 1 y1 year | - | -64.8% | -64.7% | - |
| 5 y5 years | - | - | - | - |
PRLD PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.2% | 17.95 | +3.2% | |
| 3 m | 3-month | 24.77 | -25.2% | 14.68 | +26.2% |
| 6 m | 6-month | 38.89 | -52.4% | 14.68 | +26.2% |
| 1 y | 1-year | 38.89 | -52.4% | 14.68 | +26.2% |
| 3 y | 3-year | 38.89 | -52.4% | 14.68 | +26.2% |
| 5 y | 5-year | 38.89 | -52.4% | 14.68 | +26.2% |
| alltime | all time | 38.89 | -52.4% | 14.68 | +26.2% |
Prelude Therapeutics Incorporated PS Ratio History
| Date | Value |
|---|---|
| 2025 | 18.53(-15.1%) |
| Date | Value |
|---|---|
| 2024 | 21.83 |
FAQ
- What is Prelude Therapeutics Incorporated price to sales ratio?
- What is the all time high PS ratio for Prelude Therapeutics Incorporated?
- What is PRLD price to sales ratio year-to-date change?
What is Prelude Therapeutics Incorporated price to sales ratio?
The current PS ratio of PRLD is 18.53
What is the all time high PS ratio for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high price to sales ratio is 38.89
What is PRLD price to sales ratio year-to-date change?
Prelude Therapeutics Incorporated price to sales ratio has changed by -3.30 (-15.12%) since the beginning of the year